Unknown

Dataset Information

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.


ABSTRACT: The generation of T cells from pluripotent stem cells (PSCs) is attractive for investigating T cell development and validating genome editing strategies in vitro. X-linked severe combined immunodeficiency (X-SCID) is an immune disorder caused by mutations in the IL2RG gene and characterised by the absence of T and NK cells in patients. IL2RG encodes the common gamma chain, which is part of several interleukin receptors, including IL-2 and IL-7 receptors. To model X-SCID in vitro, we generated a mouse embryonic stem cell (ESC) line in which a disease-causing human IL2RG gene variant replaces the endogenous Il2rg locus. We developed a stage-specific T cell differentiation protocol to validate genetic correction of the common G691A mutation with transcription activator-like effector nucleases

SUBMITTER: Alzubi J 

PROVIDER: S-EPMC5622068 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature